OWP Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

OWP Pharmaceuticals General Information

Description

Developer of food and drug administration (FDA) approved epilepsy medications intended to support patients and healthcare providers in neurology and psychiatry. The company specializes in developing and commercializing novel oral liquid formulations for epilepsy and associated psychiatric disorders, enabling clients to improve the lives of affected and under-resourced patients worldwide at an affordable cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 Warrenville Road
  • Suite 200
  • Lisle, IL 60532
  • United States
+1 (800)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 701 Warrenville Road
  • Suite 200
  • Lisle, IL 60532
  • United States
+1 (800)

OWP Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OWP Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
4. Later Stage VC 09-Sep-2025 Completed Generating Revenue
3. Debt - General 22-Jul-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Aug-2016 $950K $1.85M Completed Generating Revenue
1. Seed Round 01-Feb-2016 $900K $900K Completed Startup
To view OWP Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OWP Pharmaceuticals Patents

OWP Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12478584-B1 Atomoxetine hydrochloride oral suspension and use thereof Active 15-Apr-2025
US-12491157-B1 Atomoxetine hydrochloride oral suspension and use thereof Active 15-Apr-2025
US-20260315382-A1 Atomoxetine hydrochloride oral suspension and use thereof Pending 15-Apr-2025
US-20260315383-A1 Atomoxetine hydrochloride oral suspension and use thereof Pending 15-Apr-2025
US-20260315384-A1 Atomoxetine hydrochloride oral suspension and use thereof Pending 15-Apr-2025 A61K9/10
To view OWP Pharmaceuticals’s complete patent history, request access »

OWP Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OWP Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Talanton Impact Investing Minority
To view OWP Pharmaceuticals’s complete investors history, request access »

OWP Pharmaceuticals FAQs

  • When was OWP Pharmaceuticals founded?

    OWP Pharmaceuticals was founded in 2014.

  • Where is OWP Pharmaceuticals headquartered?

    OWP Pharmaceuticals is headquartered in Lisle, IL.

  • What is the size of OWP Pharmaceuticals?

    OWP Pharmaceuticals has 21 total employees.

  • What industry is OWP Pharmaceuticals in?

    OWP Pharmaceuticals’s primary industry is Drug Discovery.

  • Is OWP Pharmaceuticals a private or public company?

    OWP Pharmaceuticals is a Private company.

  • What is OWP Pharmaceuticals’s current revenue?

    The current revenue for OWP Pharmaceuticals is .

  • How much funding has OWP Pharmaceuticals raised over time?

    OWP Pharmaceuticals has raised $10M.

  • Who are OWP Pharmaceuticals’s investors?

    Talanton has invested in OWP Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process